NCT05110833View on ClinicalTrials.gov

Dose Responsiveness as a Measure of Clinical Effectiveness During Neuromonitored Spine Surgery

Enrolling by invitationOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2026

Conditions

Intervertebral Disc DegenerationIntervertebral Disc DisplacementSpinal CurvaturesSpinal StenosisSpondylitisSpondylosis

Trial Locations (1)

55447

Abbott Northwestern Hospital, Minneapolis

All Listed Sponsors

lead

Allina Health System

OTHER